Table 2 Univariate/multivariable multilevel logistic analysis for mortality and readmission in the prevalent DM cohort

Mortality

 Overall

  DPP4 inhibitor

Ref

Ref

Ref

Ref

  SGLT2 inhibitor

0.44 (0.37,0.52)

0.62(0.52,0.74)

0.67 (0.56,0.80)

0.70 (0.56,0.89)

  Both inhibitors

0.49 (0.42,0.56)

0.65 (0.56,0.74)

0.71 (0.62,0.82)

 Patients ≥ 75 years

  DPP4 inhibitor

Ref

Ref

Ref

Ref

  SGLT2 inhibitor

0.56 (0.45,0.69)

0.59 (0.48,0.74)

0.64 (0.52,0.80)

0.68 (0.51,0.90)

  Both inhibitors

0.58 (0.49,0.69)

0.63 (0.53,0.75)

0.69 (0.58,0.82)

HF readmission

 Overall

  DPP4 inhibitor

Ref

Ref

Ref

Ref

  SGLT2 inhibitor

0.43 (0.38,0.48)

0.48 (0.42,0.54)

0.50 (0.44,0.56)

0.52 (0.45,0.61)

  Both inhibitors

0.49 (0.45,0.54)

0.53 (0.49,0.59)

0.56 (0.51,0.62)

 Patients ≥ 75 years

  DPP4 inhibitor

Ref

Ref

Ref

Ref

  SGLT2 inhibitor

0.54 (0.46,0.63)

0.53 (0.45,0.62)

0.54 (0.46,0.64)

0.59 (0.47,0.74)

  Both inhibitors

0.53 (0.46,0.60)

0.52 (0.46,0.60)

0.55 (0.48,0.62)

All-cause readmission

 Overall

  DPP4 inhibitor

Ref

Ref

Ref

Ref

  SGLT2 inhibitor

0.63 (0.59,0.67)

0.65 (0.61,0.69)

0.68 (0.63,0.72)

0.72 (0.66,0.79)

  Both inhibitors

0.74 (0.70,0.78)

0.76 (0.72,0.80)

0.78 (0.74,0.83)

 Patients ≥ 75 years

  DPP4 inhibitor

Ref

Ref

Ref

Ref

  SGLT2 inhibitor

0.70 (0.64,0.77)

0.69 (0.63,0.76)

0.71 (0.64,0.78)

0.76 (0.65,0.87)

  Both inhibitors

0.76 (0.71,0.82)

0.75 (0.69,0.81)

0.77 (0.71,0.83)